Benzinga's Top Upgrades
May 27, 2015 at 09:12 AM EDT
Analysts at SunTrust Robinson Humphrey upgraded Amedisys Inc (NASDAQ: AMED) from Neutral to Buy. The price target for Amedisys has ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|